title: Need for both angiotensin converting enzyme and angiotensinase specific inhibition for a reliable assessment of angiotensin II levels in human plasma.
authors.affiliation: Clinica Medica I, University of Florence, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Boddi
authors.forename: M
authors.initials: M
authors.lastname: Coppo
authors.forename: C
authors.initials: C
authors.lastname: Rostagno
authors.forename: G F
authors.initials: GF
authors.lastname: Gensini
authors.forename: G G
authors.initials: GG
authors.lastname: Serneri
mesh_terms: D000328:Adult; D000804:Angiotensin II / Q000097:blood*; D002216:Captopril / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006973:Hypertension / Q000097:blood* / Q000188:drug therapy; D008297:Male; D007703:Peptidyl-Dipeptidase A / Q000378:metabolism*; D011480:Protease Inhibitors; D011863:Radioimmunoassay
chemical_list: D011480:Protease Inhibitors; D000804:Angiotensin II; D002216:Captopril; D007703:Peptidyl-Dipeptidase A